Monosaccharide-based compositions for diverse therapeutic and cosmetic applications

Publication ID: 24-11857662_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Monosaccharide-based compositions for diverse therapeutic and cosmetic applications,” Published Technical Disclosure No. 24-11857662_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857662_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,662.

Summary of the Inventive Concept

The inventive concept leverages the core technology of hair coloring compositions to develop novel, monosaccharide-based formulations for treating skin conditions, reducing inflammation in joints, delivering therapeutic agents, reducing the appearance of fine lines and wrinkles, and treating oral diseases.

Background and Problem Solved

The original patent disclosed hair coloring compositions comprising specific monosaccharides and surfactants. However, these compositions were limited to hair coloring applications. The new inventive concept addresses the need for effective treatments in various therapeutic and cosmetic fields by applying the core technology to new use cases.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of compositions, each tailored to a specific application. For instance, a composition for treating skin conditions consists of a first monosaccharide having 2 to 4 carbon atoms and a surfactant, which is a mixture of decyl glucoside and cetearyl glucoside. Similarly, a composition for reducing inflammation in joints incorporates a second monosaccharide having 2 to 4 carbon atoms and a polyoxyalkylene derived from polymerization of ethylene oxide. These compositions can be formulated into various delivery systems, such as devices for delivering therapeutic agents to specific sites in the body or cosmetic compositions for reducing the appearance of fine lines and wrinkles.

Novelty and Inventive Step

The new inventive concept is novel and non-obvious in its application of the core technology to diverse therapeutic and cosmetic fields, which were not contemplated in the original patent. The specific combinations of monosaccharides and surfactants, as well as the tailored formulations for each application, provide an inventive step beyond the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the type and ratio of monosaccharides, using different surfactants or polyoxyalkylenes, or incorporating additional active ingredients to enhance the efficacy of the compositions. These variations could further expand the range of potential applications and uses.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including pharmaceuticals, cosmetics, and medical devices. The target markets include skin care, joint health, therapeutic delivery, and oral care, offering opportunities for partnerships, licensing, and product development.

CPC Classifications

SectionClassGroup
A A61 A61K8/60
A A61 A61K8/046
A A61 A61K8/342
A A61 A61K8/345
A A61 A61K8/35
A A61 A61K8/4973
A A61 A61K8/604
A A61 A61Q5/065
A A61 A61Q5/10
A A45 A45D19/0066
A A45 A45D2200/155

Field of Art

Cosmetic and pharmaceutical compositions, specifically hair coloring and therapeutic formulations involving monosaccharides, surfactants, and delivery systems. Expertise requires advanced knowledge of organic chemistry, formulation science, and biochemical interactions

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in chemistry or pharmaceutical sciences, experienced in developing complex compositions, familiar with surfactant interactions, monosaccharide properties, and multi-purpose formulation strategies

Obviousness Rationale

A PHOSITA would recognize that the core monosaccharide and surfactant technology from the source patent provides a versatile platform for exploring alternative therapeutic and cosmetic applications. The fundamental chemical principles underlying the original hair coloring composition can be readily adapted to other bodily treatment contexts using predictable formulation techniques. The disclosed variations represent logical extensions of the existing technological framework using standard scientific methodology.

Obvious Combinations & Variations

Source Patent Element
Hair coloring composition using monosaccharides with 2-4 carbon atoms
PTD Variation
Applying identical monosaccharide composition principles to skin condition treatment
Obviousness Reasoning
Predictable application of known chemical composition to related dermatological use, representing standard scientific extrapolation
Source Patent Element
Surfactant mixture of decyl glucoside and cetearyl glucoside
PTD Variation
Utilizing identical surfactant combination in therapeutic agent delivery systems
Obviousness Reasoning
Known surfactant properties enable straightforward adaptation across different medical delivery contexts
Source Patent Element
Monosaccharide weight ratios and pH ranges from original patent
PTD Variation
Maintaining similar compositional parameters for joint inflammation and cosmetic treatments
Obviousness Reasoning
Consistent chemical formulation approach demonstrates predictable scaling of original technological concept
Source Patent Element
First and second monosaccharide combinations
PTD Variation
Expanding monosaccharide combinations to oral disease and wrinkle reduction applications
Obviousness Reasoning
Finite set of known monosaccharide interactions suggests systematic exploration of potential therapeutic uses
Source Patent Element
pH-controlled hair coloring composition
PTD Variation
Applying pH-controlled formulation principles to diverse therapeutic compositions
Obviousness Reasoning
Standard pharmaceutical formulation practice involves systematically adapting pH parameters across different medical applications
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed herein would have been obvious to a person having ordinary skill in the art at the time of invention, as they represent predictable extensions of the foundational technological principles established in US Patent 11857662, involving systematic adaptation of monosaccharide compositions across related therapeutic and cosmetic domains using standard scientific methodologies.

Original Patent Information

Patent NumberUS 11,857,662
TitleHair coloring compositions and methods thereof
Assignee(s)Kao USA Inc.